CPMD — CANNAPHARMARX, INC.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1081938 ·
Alberta, Canada
Last close
$0.00
Market Cap
$1.70M
52W High
$0.00
52W Low
$0.00
ADV30
261,029
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 627,462 | -409,453 | -682,343 | -382,021 | 6,580,734 | 633 | 36,850,622 |
| Dec 2025 | 138,630 | -521,091 | -893,553 | -7,549,585 | 7,018,404 | 1,804 | 37,172,133 |
| Sep 2025 | 656,606 | -440,000 | -935,646 | -1,477,811 | 11,616,907 | 927 | 34,133,650 |
| Jun 2025 | 231,608 | -621,210 | -840,980 | -1,413,458 | 11,472,755 | 16,975 | 34,046,840 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-431,377
Investing CF
$0
Financing CF
$436,321
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-112,697,611
Inventory
$902,913
Receivables
$26,008
ST Investments
—
EBIT TTM
$-8,201,817
Pretax Income TTM
$-10,822,875
Interest Exp TTM
$2,621,058
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,654,306
EBITDA
—
Free Cash Flow
$-7,014,149
Enterprise Value
$27,831,420
Total Cash
$633
Total Debt
$25,454,732
Shares Out
678,501,405
Trailing EPS
$-0.02
Book Value
$-0.05
ROE
—
ROA
-23.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,362,163 | -3,347,764 | -11,131,448 | 7,018,404 | 37,172,133 | — | -789,102 |
| Dec 2024 | 820,137 | -3,630,949 | -9,905,789 | 10,835,697 | 30,645,334 | — | -1,697,232 |
| Dec 2023 | 0 | -1,581,104 | 3,688,456 | 11,745,650 | 23,898,863 | — | -2,274,452 |
| Dec 2022 | 0 | -5,211,809 | -8,531,020 | 6,337,094 | 23,681,550 | — | -1,448,363 |
| Dec 2021 | — | — | — | — | — | — | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BSPK | Bespoke Extracts, Inc. | $1.71M | $0.15 | — |
| JAGX | Jaguar Health, Inc. | $1.67M | $2.31 | — |
| PRFX | PRF Technologies Ltd. | $1.60M | $1.84 | — |
| UPC | Universe Pharmaceuticals INC | $1.83M | $2.89 | — |
| PPBT | PURPLE BIOTECH LTD. | $1.53M | $1.64 | — |
News headlines (Yahoo Finance, 1h cache)
CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026
2026-01-13 00:00 · Yahoo
CannaPharmaRX Expands Cannabis Exports, Projects $1M+ Q3 Revenue
2025-08-19 18:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.